Wall Street Analysts Believe CorMedix (CRMD) Could Rally 142.25%: Here's is How to Trade

CorMedix (CRMD) closed the last trading session at $5.16, gaining 8.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $12.50 indicates a 142.3% upside potential. The mean estimate comprises four short-term price targets with a standard deviation of $4.51. While the lowest estimate of $9 indicates a 74.4% increase from the current price level, the most optimistic analyst expects th ...